ARCoV-005
A Global, Multi-center, Randomized, Double-Blind, Placebo-controlled, Phase III Clinical Study to Evaluate the Protective Efficacy, Safety and Immunogenicity of SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine in Population Aged 18 Years and Older
Proxalutamide
A Randomized, Double-blind, Placebo-Controlled, Phase III Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects
RECOGNISE Study
Real-world effectiveness of ChAdOx-1s, CoronaVac, BBIBP CorV, mRNA-1273, and BNT162b2 in Jakarta: test-negative design study based in existing health care data sources
Monovalen Fase-I
A Randomized, Double-Blind, and Placebo-Controlled Phase 1 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant mRNA Vaccines (ABO1009-DP and ABO-CoV.617.2) in Indonesian Subjects Aged 18 Years and Older Who Have Not Received SARS-CoV-2 Vaccines
Monovalent BA 4/5 Fase 1, 2/3
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS- CoV-2 Variant (BA.4/5) mRNA Vaccine (ABO1020) in Healthy Subjects Aged 18 Years and Older Who Have Completed the Full Vaccination
M72 TB Vaccine
A Phase 3, randomized, double-blind, placebo-controlled, multicenter, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of the investigational M72/AS01E-4 Mycobacterium tuberculosis (Mtb) vaccine when administered intramuscularly on a 0,1-month schedule to adolescents and adults
IGRA Epid Study
Epidemiological study to assess IGRA positivity in a population with a high TB burden
VaxTB Inhale Phase 1
Randomized, open-label clinical trial to evaluate the safety and tolerability of viral-vector based Tuberculosis (TB) vaccine (Ad5- 105K) in healthy people aged 18 years to 59 years
VaxTB Inhale Phase 2
Randomized, observer-blind study to evaluate the safety and immunogenicity of a viral vector-based Tuberculosis (TB) vaccine (Ad5-105K) in healthy people aged 6 years and above
1to3
A Randomized Trial Comparing Treatment Completion of Daily Rifapentine & Isoniazid for One Month (1HP) to Weekly Rifapentine & Isoniazid for 3 Months (3HP) in Persons Living with HIV and in HIV-Negative Household Contacts of Recently Diagnosed Tuberculosis Patients
Pneumococcal Invasive (IPD)
Clinical Characteristics and Serotype Distribution in Patient Hospitalized with Invasive Pneumococcal Disease
PRIMA-4TB
The Usage of Rifapentine, Isoniazid, Pyrazinamide, and Moxifloxacin Combination for 4 months for Drug-Sensitive Tuberculosis Patients in Indonesia
C-TST
Operational research for evaluating the clinical diagnostic accuracy and patient acceptance of EC-TST in Indonesian population
BGSI
Human Genomic Analysis and Mycobacterium Tuberculosis in Cases of Drug-Sensitive and Drug-Resistant Pulmonary TB in Indonesia
TOUNGE SWAB
Operational research for evaluating the clinical diagnostic accuracy and patient acceptance of EC-TST in Indonesian population
RAIT STUDY
Pulmonary Tuberculosis Prediction Using CAD4TB Artificial Intelligence (Computer-Aided Detection for Tuberculosis) Based on Thoracic X-Ray Photos among Indonesian Subjects
VIT C ZINC
Effectiveness of Vitamin C and Zinc as Adjuvant Therapy for Tuberculosis on MTB Culture Conversion
